Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Quillivant XR--an extended release oral suspension of methylphenidate.

[No authors listed]

Med Lett Drugs Ther. 2013 Feb 4;55(1409):10-1. No abstract available.

PMID:
23381227
2.

Focalin XR for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2009 Mar 23;51(1308):22-4. No abstract available.

PMID:
19305368
3.

Methylphenidate transdermal system.

Mays DA, Findling R.

J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1223. No abstract available.

PMID:
16292112
4.

Transdermal methylphenidate (Daytrana) for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2006 Jun 19;48(1237):49-51. No abstract available.

PMID:
16785850
5.

[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

Golubchik P, Sever J, Weizman A.

Harefuah. 2011 Oct;150(10):788-90, 814. Review. Hebrew.

PMID:
22111124
6.

Transdermal methylphenidate system: old wine in a new bottle.

Bukstein OG.

Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):661-5. doi: 10.1517/17425250902960148. Review.

PMID:
19442029
7.

Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.

Moen MD, Keam SJ.

CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000. Review.

PMID:
19958043
8.

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.

Ross RG.

Am J Psychiatry. 2006 Jul;163(7):1149-52. No abstract available.

PMID:
16816217
9.

Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl.

Goetz M, Surman CB, Mlynarova E, Krsek P.

J Clin Psychopharmacol. 2012 Apr;32(2):300-2. doi: 10.1097/JCP.0b013e3182499a16. No abstract available.

PMID:
22388167
10.

Dexmethylphenidate extended release: in attention-deficit hyperactivity disorder.

Robinson DM, Keating GM.

Drugs. 2006;66(5):661-8; discussion 669-70.

PMID:
16620143
12.
13.

Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.

Lewis H, Lewis J.

Atten Defic Hyperact Disord. 2012 Mar;4(1):37-9. doi: 10.1007/s12402-012-0071-9. Epub 2012 Feb 5.

PMID:
22311620
14.

Pharmacology of adult ADHD with stimulants.

Spencer TJ.

CNS Spectr. 2007 Apr;12(4 Suppl 6):8-11. No abstract available.

PMID:
17715564
15.

Cmap ADHD and comorbid aggression algorithm.

Sharp BW.

J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):1; author reply 1-3. No abstract available.

PMID:
17195721
16.

Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.

Fernández-Jaén A, Fernández-Mayoralas DM, Pardos A, Calleja-Pérez B, Muñoz Jareño N.

Adv Ther. 2009 Dec;26(12):1097-110. doi: 10.1007/s12325-009-0083-9. Epub 2010 Jan 16.

PMID:
20082241
17.

The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.

Childress A, Sallee FR.

Expert Rev Neurother. 2013 Sep;13(9):979-88. doi: 10.1586/14737175.2013.833002. Review.

PMID:
24053342
18.

[How safe are ADHD drugs?].

Schwarz R, Muskalla B.

Kinderkrankenschwester. 2005 Oct;24(10):437. German. No abstract available.

PMID:
16262203
19.

[Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].

Oberpichler-Schwenk H.

Med Monatsschr Pharm. 2006 Nov;29(11):415-6. Review. German. No abstract available.

PMID:
17131689
20.

OROS methylphenidate-induced skin eruptions.

Coskun M, Tutkunkardas MD, Zoroglu S.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):593-4. doi: 10.1089/cap.2009.0009. No abstract available.

PMID:
19877987
Items per page

Supplemental Content

Write to the Help Desk